January 2026

Medical Journal January 2026 Digital Edition

January 22, 202614 min

slot88 bakautoto toto togel bakautoto slot gacor toto slot slot gacor toto slot toto togel link slot gacor bet togel situs toto legianbet slot toto slot slot gacor legianbet legianbet agen sbobet legianbet legianbet slot thailand toto togel situs togel togel online toto togel situs slot link togel slot online togel online toto togel situs togel situs toto toto togel situs toto kawijitu situs toto kawijitu toto slot situs toto toto online situs slot situs...

Legal Affairs

Headed for another shutdown? How the expiration of the ACA Tax Credits questions could impact healthcare providers

January 21, 202617 min

BY Amanda F. Hobbs, Esq. and Michael Alexander, Esq., Brown & Fortunato, P.C. October 1, 2025, kicked off the longest government shutdown in U.S. history, lasting 43 days total. Come January 30, 2026, we may be in for an even longer standoff should no bipartisan agreement come to fruition. So, what had lawmakers so riled up? And why might it happen again so soon? To answer this question, we have to look at...

Financial Perspectives

How proactive hospital capacity management can create financial value

January 21, 202620 min

BY Amy Gonzalez, Managing Director, Strategy & Execution, & Dr. Matthew Weiss, Managing Director, EY-Parthenon, Ernst & Young LLP An improved hospital capacity management strategy can unlock value and boost financial performance. Many health system leaders remain financially cautious amid cost pressures and regulatory uncertainty. Hospital capacity management can establish an operational backbone, make health care networks more efficient, and improve cash flow and operating margins. It can also help systems differentiate themselves in...

Integrative Medicine

What are the benefits of Hydrogen Therapy?

January 21, 202614 min

BY Samuel Mathis MD Recently, I’ve been asked about the medical uses of hydrogen therapy as an integrative treatment. Having never heard of this therapy before led me down a deep rabbit hole into the claims and science behind hydrogen therapy. Although it is still relatively new, this therapy has a lot of potential. Let’s review the science behind it. Hydrogen therapy is an integrative therapy that includes ingesting, inhalation, infusion with hydrogen-rich...

THA

With large federal rural health award, promising possibilities abound for Texas

January 21, 202613 min

BY John Hawkins Many of us look at a new year as a new beginning – and if the year ahead is going to be better than the one preceding it, it’s good to start your journey with positives and reasons for optimism. Thanks to an historic investment from our federal government, Texas’ rural hospitals and communities are starting the year with 281 million reasons to believe in a better future. Just before...

Hospital Headlines

UTMB study shows potential treatment of Lassa fever with antiviral drug

January 21, 202612 min

Researchers at The University of Texas Medical Branch (UTMB), funded by a National Institutes of Health grant, show that antiviral medicine successfully treated non-human primates infected with the virus that causes Lassa fever. Lassa fever remains a global health threat Lassa fever is a hemorrhagic disease for which there is currently no treatment. It is estimated to cause 100,000 to 300,000 infections and 5,000 deaths annually in West Africa with Nigeria accounting for a...

Hospital Headlines

MD Anderson and SOPHiA GENETICS announce strategic collaboration to accelerate AI-driven precision oncology

January 21, 202610 min

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics with MD Anderson’s clinical and scientific expertise to accelerate data-driven cancer care through new tools that can accurately analyze, interpret and translate diagnostic results into clinical practice. As part of the collaboration, MD Anderson and SOPHiA GENETICS are launching a series of research and development programs and co-developing an advanced next-generation sequencing oncology test. Built on the...

Hospital Headlines

New Study Identifies Molecular Clues Behind Mixed Immunotherapy Response in Colon Cancer Patients

January 21, 202613 min

Patients with a particularly aggressive form of metastatic colorectal cancer may benefit from a novel combination of targeted therapy and immunotherapy, according to a Houston-led phase 1/2 clinical trial that offers new insights into why some patients benefit while others don’t. The multi-institutional clinical trial showed significantly better outcomes from a three-drug regimen of encorafenib, cetuximab and the immune checkpoint inhibitor nivolumab in patients with microsatellite-stable (MSS) colorectal cancer harboring the BRAFV600E mutation than...